AIRS
AirSculpt Technologies, Inc. NASDAQ Listed Oct 29, 2021$4.94
+2.70%
vs $4.81
Mkt Cap $348.5M
52w Low $1.51
32.7% of range
52w High $12.00
50d MA $4.10
200d MA $4.41
P/E (TTM)
-26.0x
EV/EBITDA
279.1x
P/B
3.4x
Debt/Equity
0.9x
ROE
-13.3%
P/FCF
431.5x
RSI (14)
42.80
ATR (14)
$0.43
Beta
2.27
50d MA
$4.10
200d MA
$4.41
Avg Volume
1.0M
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. It offers custom body contouring using its AirSculpt procedure that removes unwanted fat in a minimally invasive procedure. The company provides fat removal procedures across treatment areas; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. Its body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. As of March 10, 2022, it operated 19 centers across 15 states. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.
400 Alton Road · Miami Beach, FL 33139 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | BMO | -0.03 | 0.02 | +180.0% | 2.73 | -5.5% | +16.1% | -2.2% | -5.2% | -7.5% | -0.4% | — |
| Nov 7, 2025 | BMO | -0.01 | -0.04 | -300.0% | 10.49 | -30.4% | -41.7% | +3.6% | -9.0% | +5.7% | -6.2% | — |
| Aug 1, 2025 | BMO | 0.02 | 0.02 | +0.0% | 6.61 | -16.8% | -10.4% | +1.9% | -0.2% | +2.2% | +0.8% | — |
| May 2, 2025 | BMO | -0.03 | -0.02 | +33.3% | 2.26 | +26.5% | +33.6% | -19.5% | -5.3% | +11.3% | +10.5% | — |
| Mar 14, 2025 | BMO | 0.02 | -0.08 | -500.0% | 2.94 | -13.6% | -2.7% | -8.0% | -1.5% | +15.4% | -6.0% | — |
| Nov 8, 2024 | BMO | -0.01 | -0.02 | -100.0% | 7.19 | +8.3% | +20.7% | -4.0% | -4.2% | -7.1% | -6.1% | — |
| Aug 9, 2024 | BMO | 0.13 | 0.09 | -30.8% | 3.94 | -18.8% | +1.0% | -13.8% | +7.6% | +1.6% | +3.7% | — |
| May 10, 2024 | BMO | 0.08 | 0.03 | -62.5% | 5.39 | -6.3% | -12.1% | -1.5% | -2.4% | -2.2% | -3.1% | — |
| Feb 27, 2024 | BMO | 0.11 | 0.01 | -90.9% | 6.31 | -13.5% | -2.1% | -2.1% | +4.3% | -0.5% | -5.1% | — |
| Nov 9, 2023 | BMO | 0.09 | 0.05 | -44.4% | 6.18 | +1.8% | -9.1% | -0.7% | -10.0% | +11.6% | -8.0% | — |
| Aug 11, 2023 | BMO | 0.15 | 0.13 | -13.3% | 7.86 | -1.0% | -1.8% | +0.0% | +1.7% | +0.6% | -4.1% | — |
| May 12, 2023 | BMO | 0.05 | 0.10 | +100.0% | 4.89 | +24.1% | +37.4% | +2.2% | -0.4% | +6.6% | +10.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $2.29 | $2.20 | -3.9% | +2.2% | -8.1% | -2.3% | -5.7% | +0.0% |
| Jan 17 | Piper Sandler | Maintains | Neutral → Neutral | — | $4.93 | $4.91 | -0.4% | +8.1% | -0.8% | -4.2% | +3.7% | -2.9% |
| Jan 6 | Piper Sandler | Maintains | Neutral → Neutral | — | $5.85 | $5.76 | -1.5% | +2.2% | +1.2% | -0.3% | -0.8% | -19.9% |
| May 14 | Leerink Partners | Downgrade | Outperform → Market Perform | — | $4.67 | $4.75 | +1.7% | -2.4% | -2.2% | -3.1% | +7.9% | -7.5% |
| Nov 16 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $5.15 | $5.17 | +0.4% | -3.1% | -1.0% | +11.3% | +0.0% | -1.3% |
| Aug 22 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $7.67 | $7.79 | +1.6% | -2.1% | +6.8% | -3.1% | +2.1% | +0.5% |
| Aug 21 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $7.82 | $7.88 | +0.8% | -1.9% | -2.1% | +6.8% | -3.1% | +2.1% |
| Aug 1 | Raymond James | Maintains | Outperform → Outperform | — | $9.07 | $9.04 | -0.3% | +0.6% | -4.2% | +2.4% | -2.2% | -0.7% |
| Mar 13 | Raymond James | Maintains | Outperform → Outperform | — | $4.40 | $4.32 | -1.8% | +4.3% | +5.0% | +2.9% | -2.8% | -1.9% |
| Jan 17 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $4.98 | $4.97 | -0.2% | -6.0% | -1.9% | +7.2% | +2.0% | +5.8% |
| Nov 15 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $2.70 | $2.76 | +2.2% | +14.4% | +13.9% | -6.2% | +3.3% | -7.9% |
| Nov 14 | Raymond James | Maintains | Outperform → Outperform | — | $3.28 | $3.16 | -3.7% | -17.7% | +14.4% | +13.9% | -6.2% | +3.3% |
| Nov 14 | SVB Leerink | Maintains | Outperform → Outperform | — | $3.28 | $3.16 | -3.7% | -17.7% | +14.4% | +13.9% | -6.2% | +3.3% |
| Aug 24 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $9.81 | $9.86 | +0.5% | +0.8% | -6.8% | -2.9% | -0.1% | -1.3% |
| Jun 16 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $8.17 | $7.59 | -7.1% | -22.3% | -5.8% | +5.4% | +4.8% | +0.0% |
| Mar 14 | SVB Leerink | Maintains | Outperform → Outperform | — | $13.28 | $13.64 | +2.7% | -10.8% | +5.6% | +3.5% | +5.3% | +2.2% |
No insider trades available.
8-K
AirSculpt Technologies, Inc. -- 8-K Filing
May 14
8-K · 2.02
!! High
AirSculpt Technologies, Inc. -- 8-K 2.02: Earnings Results
AirSculpt Technologies reported earnings results, with details available in the attached press release, though the filing itself provides no specific financial metrics or performance outcomes.
May 8
8-K
Unknown — 8-K Filing
AIRS maintained its 2026 guidance despite accounting principle adjustments, signaling management confidence in core business trajectory and reducing near-term investor concerns about guidance reliability.
Apr 6
8-K
Unknown — 8-K Filing
AirSculpt's fiscal 2025 results announcement will reveal revenue growth, profitability trends, and procedure volume metrics that determine whether the company can sustain its premium positioning in the competitive aesthetic surgery market.
Apr 2
NT 10-K
!!! Very High
Unknown — Late Annual Report — Distress Signal
AirSculpt's late annual report filing signals potential financial distress or operational challenges, raising investor concerns about transparency, compliance issues, and possible delisting risk if filings aren't caught up quickly.
Mar 16
8-K
Unknown — 8-K Filing
AirSculpt delayed its quarterly filing due to accounting complexities, signaling potential internal control weaknesses that could concern investors about financial reporting reliability and governance quality.
Mar 16
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Wexford Capital Lp | 670,517 | $2M | — | Mar 2026 |
| 2 | Ubs Group Ag | 622,292 | $2M | Added | Mar 2026 |
| 3 | Susquehanna International Group, Llp | 474,445 | $1M | New | Mar 2026 |
| 4 | Aqr Capital Management Llc | 309,329 | $875K | Added | Mar 2026 |
| 5 | Tudor Investment Corp | 276,679 | $783K | New | Mar 2026 |
| 6 | Citizens Financial Group Inc/ri | 265,861 | $752K | Added | Mar 2026 |
| 7 | Jane Street Group, Llc | 362,900 | $719K | Added | Dec 2025 |
| 8 | Vanguard Capital Management Llc | 233,632 | $661K | New | Mar 2026 |
| 9 | Vanguard Portfolio Management Llc | 138,272 | $391K | New | Mar 2026 |
| 10 | Morgan Stanley | 149,380 | $296K | Added | Dec 2025 |
| 11 | Northern Trust Corp | 101,747 | $288K | Reduced | Mar 2026 |
| 12 | Nuveen, Llc | 90,900 | $257K | Added | Mar 2026 |
| 13 | Simplex Trading, Llc | 84,478 | $239K | New | Mar 2026 |
| 14 | Barclays Plc | 76,917 | $218K | Added | Mar 2026 |
| 15 | Marshall Wace, Llp | 76,056 | $215K | Reduced | Mar 2026 |
| 16 | Two Sigma Investments, Lp | 66,071 | $187K | Reduced | Mar 2026 |
| 17 | Citadel Advisors Llc | 62,500 | $177K | New | Mar 2026 |
| 18 | Sei Investments Co | 60,167 | $170K | New | Mar 2026 |
| 19 | Citigroup Inc | 71,247 | $141K | Reduced | Dec 2025 |
| 20 | Ieq Capital, Llc | 48,097 | $136K | New | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$348.5M
Enterprise Value
$340.8M
P/E (TTM)
-26.00x
Forward P/E
—
PEG Ratio
-0.29x
P/B
3.40x
P/S
1.97x
P/FCF
431.54x
EV/EBITDA
279.08x
Shares Out
60.5M
Financials (TTM)
Revenue
$151.8M
Net Income
-$11.7M
EBITDA
$1.2M
Free Cash Flow
$692K
Op Cash Flow
$3.1M
EPS Basic
$-0.19
EPS Diluted
$-0.19
EPS Forward
$-0.05
Gross Margin
59.4%
Op Margin
-3.2%
Net Margin
-7.7%
Balance Sheet
Total Assets
$187.3M
Total Liab.
$99.6M
Total Equity
$87.7M
Cash
$8.4M
LT Debt
$50.6M
Book Value/Sh
$1.45
Debt/Equity
0.95x
Current Ratio
0.55
Quick Ratio
0.55
Returns & Growth
ROE
-13.3%
ROA
-6.2%
ROIC
-1.9%
Rev Growth YoY
-15.8%
EPS Growth YoY
-35.7%
Price Returns
2W
+13.5%
1M
+100.7%
3M
+240.5%
6M
+52.4%
12M
+22.0%
Technicals
52W High
$12.00
52W Low
$1.51
50d MA
$4.10
200d MA
$4.41
RSI (14)
42.80
ATR (14)
$0.43
Beta
2.27
Avg Volume
1.0M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
Aug 25, 2022
Analyst Price Targets
Consensus
$6.00
High
$6.00
Low
$6.00
Median
$6.00
Data updated apr 24, 2026 4:58pm
· Source: financialmodelingprep.com